Both groups had improved left ventricular function , but change in left ventricular ejection fraction was lower in patients treated with G-CSF than in those who received placebo ( 5.7 [ 95 % CI 3.4-8 .1 ] percentage points v. 9.2 [ 95 % CI 6.3-12 .1 ] percentage points ) .